We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MHO:NYSEM/I Homes, Inc. Analysis

Data as of 2026-06-28 - not real-time

$163.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

M/I Homes is trading at the upper end of its 52‑week range ($163, near the $163.66 resistance) with an RSI of 77.9 indicating overbought conditions, while the MACD remains bullish but the histogram is modest. The stock’s price is well above the DCF‑derived fair value of $80, suggesting a valuation stretch despite attractive multiples (PE 12.2, forward PE 10.7, P/B 1.31). Revenue has contracted ‑5.7% year‑over‑year, yet margins remain solid (gross 21.6%, operating 9%, profit 8.2%) and leverage is moderate (debt‑to‑equity 31.7%). Volatility is high at 37.8% over the past 30 days and the Fear‑Greed Index reads Extreme Greed, reflecting heightened market enthusiasm that may be unsustainable.
The technical picture shows a bullish trend (price above the 20‑day SMA of 143.66 and 50‑day SMA of 135.00) but the combination of overbought momentum, proximity to resistance, and a negative revenue trend warrants caution. With no dividend and a modest cash‑to‑debt cushion, the upside appears limited in the near term, while the longer‑term outlook could improve if the housing cycle stabilizes and the company leverages its geographic diversification across eight states.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price at resistance with overbought RSI
  • DCF fair value far below market price
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Solid profit margins despite revenue decline
  • Moderate leverage and positive cash position
  • Technical bullish trend above key moving averages

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Geographic diversification across eight states
  • Potential stabilization of the residential construction cycle
  • Attractive valuation multiples relative to peers

Key Metrics & Analysis

Financial Health

Revenue Growth-5.70%
Profit Margin8.24%
P/E Ratio12.2
ROE11.60%
ROA6.49%
Debt/Equity31.69
P/B Ratio1.3
Op. Cash Flow$208.2M
Free Cash Flow$172.8M

Technical Analysis

TrendBullish
RSI77.9
Support$131.08
Resistance$163.66
MA 20$143.66
MA 50$135.00
MA 200$134.40
MACDBullish
VolumeIncreasing
Fear & Greed Index88.55

Valuation

Fair Value$79.98
Target Price$163.33
Upside/Downside0.20%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.97
Volatility37.83%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.